Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS)

NCT01276236 PHASE2 COMPLETED Results posted

The purpose of this pilot study is to determine whether Maraviroc is effective in the treatment of Kaposi's Sarcoma (KS), when it does not remit with standard antiretroviral drug therapy.

Details

Lead sponsor	University of California, San Francisco
Phase	PHASE2
Status	COMPLETED
Enrolment	13
Start date	Wed Mar 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Apr 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Kaposi's Sarcoma

Interventions

• Maraviroc

Countries

United States